AntibioticDB

RP60556A

Benzo[b]naphthyridone

Aventis (Sanofi-Aventis, France)

2000

Highest development stage: Preclinical
Development status: Inactive
Gram-negative activity
Mechanism of Action/Target pathogen: Topical treatment
GtoPDB link: https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=11006
Source: https://www.sciencedirect.com/science/article/pii/S0960894X01000919?via%3Dihub
Compound/Drug Structure: https://pubchem.ncbi.nlm.nih.gov/compound/484065